2,4,6-trihydroxyacetophenone has been researched along with resacetophenone in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baldasso, P; Calgarotto, AK; Comar, M; da Silva, SL; Damico, DC; Marangoni, S; Maso, V; Oliveira, AR; Oliveira, KM; Veber, CL; Villar, JA | 1 |
| Buolamwini, JK; Gupte, A | 1 |
| Bruyère, C; Curini, M; Epifano, F; Genovese, S; Ionescu-Motatu, A; Kiss, R; Lallemand, B | 1 |
3 other study(ies) available for 2,4,6-trihydroxyacetophenone and resacetophenone
| Article | Year |
|---|---|
Molecular modeling and inhibition of phospholipase A2 by polyhydroxy phenolic compounds.
Topics: Animals; Crotalid Venoms; Drug Design; Edema; Enzyme Inhibitors; Humans; Kinetics; Models, Molecular; Phenols; Phospholipase A2 Inhibitors | 2009 |
Synthesis and biological evaluation of phloridzin analogs as human concentrative nucleoside transporter 3 (hCNT3) inhibitors.
Topics: Chemistry, Pharmaceutical; Drug Design; Equilibrative Nucleoside Transporter 1; Furans; Humans; Kinetics; Ligands; Membrane Transport Proteins; Models, Chemical; Nucleoside Transport Proteins; Nucleosides; Phlorhizin | 2009 |
Growth inhibitory activities of oxyprenylated and non-prenylated naturally occurring phenylpropanoids in cancer cell lines.
Topics: Acetophenones; Acrolein; Anthraquinones; Antineoplastic Agents; Apoptosis; Benzoates; Biological Products; Cell Line, Tumor; Chalcones; Cinnamates; Coumarins; Drug Screening Assays, Antitumor; Humans; Prenylation; Propanols | 2011 |